Esperion Therapeutics
ESPR
#6605
Rank
โ‚ฌ0.71 B
Marketcap
2,79ย โ‚ฌ
Share price
0.00%
Change (1 day)
184.36%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): โ‚ฌ67.48 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚ฌ0.41 Billion. In 2025 the company made an earning of โ‚ฌ55.85 Million, an increase over its 2024 earnings that were of โ‚ฌ6.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ67.48 M20.81%
2025 โ‚ฌ55.85 M749.49%
2024 โ‚ฌ6.57 M-104.99%
2023 -โ‚ฌ0.14 Billion-15.03%
2022 -โ‚ฌ0.16 Billion-20.61%
2021 -โ‚ฌ0.2 Billion84.28%
2020 -โ‚ฌ0.11 Billion35.75%
2019 -โ‚ฌ78.01 Million-55.71%
2018 -โ‚ฌ0.18 Billion19.57%
2017 -โ‚ฌ0.15 Billion125.39%
2016 -โ‚ฌ65.36 Million51.43%
2015 -โ‚ฌ43.16 Million36.45%
2014 -โ‚ฌ31.63 Million43.55%
2013 -โ‚ฌ22.04 Million145.26%
2012 -โ‚ฌ8.99 Million
2002 -โ‚ฌ25.62 Million-7.81%
2001 -โ‚ฌ27.79 Million15.03%
2000 -โ‚ฌ24.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ9.27 B 13,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ4.51 B 6,395.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.48 Billion-775.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚ฌ22.86 Million-132.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ0.16 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.33 B 385.70%๐Ÿ‡บ๐Ÿ‡ธ USA